Plain-English translation of NCT07225296 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called to understand how it works and how safe it is in healthy adult volunteers. Researchers will give some people the medication in increasing doses—first as a single dose, then as daily doses over two weeks—while others receive a placebo (inactive pill) to compare. The goal is to gather basic safety information before this medication moves forward in development.
Before any new medication can be tested in patients with a real disease, it must first be studied in healthy people to make sure it doesn't cause serious side effects and to understand how the body processes it. This early information is essential for protecting patients in future trials.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll be randomly assigned to receive either the medication or a placebo. In the first part of the study, you'll take a single dose and be monitored for safety. In the second part, you'll take daily doses for 14 consecutive days while researchers check your blood pressure, heart rhythm, and blood work. You'll need to visit the clinic multiple times and stay overnight for some visits so doctors can closely watch how your body responds.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States